Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework.

Journal of medical ultrasonics (2001)·2026

Same author

Combined Large Cell Neuroendocrine Carcinoma With Enteric-Type Adenocarcinoma of the Lung.

Pathology international·2026

Same author

Cytological Appearances of Colorectal Adenocarcinoma Cells in Urine.

Cytopathology : official journal of the British Society for Clinical Cytology·2025

Same author

Identification of a PCNA-binding motif in human translesion DNA polymerase REV1 and structural basis of its interaction with PCNA.

Journal of biochemistry·2025

Same author

Characterization of the fatty acid composition of Pacific bluefin tuna Thunnus orientalis larvae by body part and depending on growth rate.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2025

Same author

Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases From Ovarian Cancer.

Anticancer research·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Aberrant MAD2 expression in soft-tissue sarcoma.

Masanori Hisaoka¹, Atsuji Matsuyama, Hiroshi Hashimoto

¹Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. hisaoka@med.uoeh-u.ac.jp

Pathology International

|May 15, 2008

Summary

This summary is machine-generated.

Aberrant expression of MAD2 (mitotic arrest deficient 2) is linked to pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas. This finding is particularly relevant for high-grade translocation-associated sarcomas.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Experiment Videos

Last Updated: Jul 5, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Area of Science:

Oncology
Cell Biology
Molecular Pathology

Background:

Soft-tissue sarcomas are categorized as translocation-associated (TA) or non-TA.
Non-TA sarcomas often exhibit pleomorphic cytomorphology and aneuploidy.
MAD2, a mitotic spindle checkpoint component, is implicated in promoting aneuploidy.

Purpose of the Study:

To investigate MAD2 expression via immunohistochemistry in TA and non-TA soft-tissue sarcomas.
To correlate MAD2 status with tumor morphology, grade, and mitotic abnormalities.

Main Methods:

Immunohistochemistry was performed on 100 soft-tissue sarcoma samples (50 TA, 50 non-TA).
MAD2 expression levels were assessed and correlated with cytomorphology, fusion gene status, and mitotic figures.

Main Results:

MAD2 overexpression was observed in 52% of TA sarcomas and 66% of non-TA sarcomas.
Overexpression was more frequent in high-grade TA sarcomas with atypical morphology.
MAD2-overexpressing sarcomas showed significantly more abnormal mitotic figures (P = 0.003).

Conclusions:

Aberrant MAD2 expression is associated with pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas.
MAD2 overexpression may contribute to high-grade progression in the TA subset of sarcomas.